查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1971513

機器人輔助內視鏡市場－全球產業規模、佔有率、趨勢、機會、預測：按最終用戶、地區和競爭對手分類，2021-2031年

Robot-assisted Endoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End User (Hospitals, Outpatient Facilities, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球機器人輔助內視鏡市場預計將從 2025 年的 15.1 億美元成長到 2031 年的 23.6 億美元，複合年成長率為 7.73%。

這些電子機械設備旨在輔助醫生診斷和治療消化器官系統疾病，與傳統手動器械相比，它們具有更優異的穩定性、可視性和操作性。市場成長的主要促進因素是慢性消化系統疾病盛行率的上升以及對能夠縮短住院時間的微創手術需求的不斷成長。例如，美國癌症協會 (ACS) 估計，到 2024 年，美國將新增約 152,810 例結直腸癌病例，這凸顯了這些技術所面臨的疾病負擔之重。

市場概覽
預測期 2027-2031
市場規模：2025年 15.1億美元
市場規模：2031年 23.6億美元
複合年成長率：2026-2031年 7.73%
成長最快的細分市場 門診部
最大的市場 北美洲

儘管成長要素強勁，但由於機器人平台的高昂購買和維修成本，市場仍面臨許多障礙。這些經濟障礙限制了機器人技術的普及，尤其是在小規模的醫療機構和報銷機制不完善的發展中地區。此外，醫護人員掌握這些複雜系統所需的學習曲線陡峭，也造成了營運瓶頸。這些經濟和培訓方面的限制持續阻礙機器人輔助技術在標準臨床實踐中的廣泛應用。

市場促進因素

人工智慧的進步和軟性機器人平台的開發正在從根本上改變全球機器人輔助內視鏡市場，使醫生能夠進入以往難以觸及的解剖結構。軟體機器人和可操控導管的創新使醫生能夠比使用手動器械更穩定、更精確地在肺部和消化道的複雜路徑中穿梭。這項技術進步證明了複雜平台的安全性，並加速了其商業化進程。 2024年12月，EndoQuest Robotics在新聞稿中宣布，美國FDA已核准其柔軟性腔手術系統研究醫療設備豁免（IDE），允許其開展結直腸手術的臨床試驗，這標誌著該領域取得了重大進展，也證實了這些技術已接近臨床應用成熟階段。

肺部和胃腸道疾病的日益普遍正顯著推動市場擴張，因為醫療服務提供者面臨越來越大的壓力，需要提供微創切片檢查和治療性介入。肺癌等複雜疾病發生率的上升，需要先進的診斷工具來提高早期檢出率，推動了機器人輔助支氣管鏡檢查的廣泛應用。例如，美國肺臟協會 (ALA) 的《2024 年肺癌現況報告》預測，2024 年美國將新增約 23.5 萬例肺癌病例。疾病數量的增加直接促進了在現有平台上進行的手術數量。因此，直覺外科公司 (Intuitive Surgical) 在 2024 年 10 月的收益報告中宣布，使用其 Ion Lumen 手術系統進行的手術數量同比成長約 73%，證實了這些技術在臨床實踐中的快速普及。

市場挑戰

全球機器人輔助內視鏡市場成長的主要障礙在於這些先進平台的高昂購買和維修成本。這一沉重的經濟負擔限制了市場滲透率，尤其是在利潤微薄的小規模區域醫院和門診手術中心。當醫療機構面臨預算限制時，它們往往優先考慮必要的營運支出，而非投資昂貴的先進技術，因為這些技術尚未建立完善的報銷機制。因此，難以證明這些高成本系統的投資報酬率（ROI）直接阻礙了機器人輔助內視鏡的廣泛應用。

近期行業數據顯示，醫療機構面臨沉重的財務負擔，進一步印證了上述經濟壓力。根據美國醫院協會 (AHA) 預測，到 2024 年，醫院設施、設備和資本財的平均使用壽命將延長 10% 以上。這是因為不斷上漲的營運成本和不足的報銷迫使醫療機構推遲購買新的醫療技術。資本支出的減少對機器人輔助內視鏡市場產生了負面影響，因為醫療機構管理者被迫推遲或取消高價值電子機械設備的採購，轉而優先維護現有的低成本手動器械。

市場趨勢

遠端手術和遠端臨床監測解決方案的發展正在突破地域限制，擴大專科胃腸病護理的覆蓋範圍。先進的機器人系統與低延遲通訊網路相結合，使專家能夠遠端操作內視鏡，讓醫療資源匱乏地區的患者無需出行即可及時接受治療。對於需要專業技術的複雜手術而言，這項技術尤其重要，因為它能夠有效地普及高品質診斷服務。例如，《醫療IT新聞》在遠端醫療年9月報道，香港中文大學和蘇黎世聯邦理工學院的一個研究團隊成功地在相距5700英里（約9200公里）的香港，透過瑞士主機遠端操控磁性切片檢查，對活體組織切片豬模型進行了活體組織切片，這充分展現了遠距醫療的潛力。

同時，自主導航和磁力操控技術的出現正在徹底改變內視鏡檢查的侵入性和工作流程。與傳統的手動操作器械和機械導管不同，新一代平台利用外部磁場精確引導可吞嚥膠囊或軟式內視鏡在商業性內移動。這顯著降低了患者的不適感，通常無需鎮靜。這種磁力驅動、無纜線運動方式最大限度地減少了組織損傷，簡化了手術操作，並使其適用於各種臨床環境。例如，2024年6月，《機器人報告》報告稱，Endiatx公司已獲得700萬美元的資金籌措，用於推進其PillBot系統的臨床開發。 PillBot系統是一種可吞嚥的機器人膠囊，可由醫生在胃內進行主動操控。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球機器人輔助內視鏡市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依最終用戶（醫院、門診等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美機器人輔助內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲機器人輔助內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區機器人輔助內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲機器人輔助內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美機器人輔助內視鏡市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球機器人輔助內視鏡市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Asensus Surgical Inc
  • Intuitive Surgical Inc
  • Auris Health Inc
  • Johnson & Johnson Services, Inc.
  • Brainlab AG
  • Medtronic PLC
  • Boston Scientific Corp
  • Stryker Corp

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21762

The Global Robot-assisted Endoscope Market is projected to expand from USD 1.51 Billion in 2025 to USD 2.36 Billion by 2031, reflecting a CAGR of 7.73%. These electromechanical devices are engineered to augment physician capabilities during gastrointestinal diagnostic and therapeutic procedures, offering superior stability, visualization, and dexterity compared to traditional manual instruments. Market growth is largely driven by the rising prevalence of chronic digestive disorders and a growing preference for minimally invasive interventions that shorten hospitalization times. Highlighting the significant disease burden necessitating such technologies, the American Cancer Society reported that approximately 152,810 new cases of colorectal cancer were estimated to be diagnosed in the United States in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.51 Billion
Market Size 2031USD 2.36 Billion
CAGR 2026-20317.73%
Fastest Growing SegmentOutpatient Facilities
Largest MarketNorth America

Despite these strong growth drivers, the market encounters substantial obstacles due to the high capital acquisition and maintenance costs linked to robotic platforms. This financial barrier restricts adoption, particularly among smaller healthcare facilities and in developing regions where reimbursement frameworks may be inadequate. Additionally, the steep learning curve required for medical professionals to master these complex systems creates an operational bottleneck. These economic and training constraints continue to hinder the widespread integration of robot-assisted technologies into standard clinical practice.

Market Driver

Advancements in artificial intelligence and the creation of flexible robotic platforms are fundamentally transforming the Global Robot-assisted Endoscope Market by enabling access to anatomical structures that were previously unreachable. Innovations in soft robotics and steerable catheters allow physicians to navigate complex pathways within the lungs and gastrointestinal tract with greater stability and precision than manual instruments. This technical progress is validating the safety of complex platforms and accelerating their commercialization path. A significant milestone occurred in December 2024, when EndoQuest Robotics announced via press release that the U.S. FDA granted an Investigational Device Exemption (IDE) for its flexible Endoluminal Surgical System to commence trials for colorectal procedures, confirming the maturity of these technologies for clinical adoption.

The growing prevalence of pulmonary and gastrointestinal disorders significantly fuels market expansion as healthcare providers face increasing pressure to perform biopsies and therapeutic interventions with minimal trauma. The rising incidence of complex conditions, such as lung cancer, necessitates advanced diagnostic tools capable of delivering higher yield rates for early-stage detection, thereby driving the utilization of robot-assisted bronchoscopy. For instance, the American Lung Association's '2024 State of Lung Cancer' report projected approximately 235,000 new lung cancer diagnoses in the United States in 2024. This escalating disease volume directly boosts procedure counts for established platforms; consequently, Intuitive Surgical reported in its October 2024 financial results that procedure volume for the Ion endoluminal system grew by approximately 73% year-over-year, underscoring the rapid clinical integration of these technologies.

Market Challenge

The primary obstacle hindering the growth of the Global Robot-assisted Endoscope Market is the high capital acquisition and maintenance costs associated with these advanced platforms. This substantial financial burden limits market penetration, particularly within smaller community hospitals and ambulatory surgical centers operating on narrow margins. When healthcare facilities face budget constraints, they often prioritize essential operational expenses over investing in premium, high-cost technologies that lack robust reimbursement pathways. Consequently, the difficulty in justifying the return on investment for these expensive systems directly stalls the broader adoption of robot-assisted endoscopy.

This economic pressure is further evidenced by recent industry data highlighting the financial strain on healthcare providers. According to the American Hospital Association, the average age of hospital plant and capital equipment increased by over 10% in 2024 as facilities were forced to delay purchasing new medical technologies due to rising operational costs and insufficient reimbursement. This contraction in capital spending power negatively impacts the robot-assisted endoscope market, as healthcare administrators are compelled to defer or cancel the acquisition of high-value electromechanical devices in favor of maintaining existing, lower-cost manual instruments.

Market Trends

The development of telesurgery and remote clinical monitoring solutions is expanding the availability of specialized gastrointestinal care by overcoming geographical limitations. Advanced robotic systems integrated with low-latency communication networks now allow expert physicians to manipulate endoscopes from distant locations, ensuring that patients in underserved regions can receive timely interventions without the need for travel. This capability is particularly vital for complex procedures where the requisite technical expertise is concentrated in major medical centers, effectively democratizing access to high-quality diagnostics. Validating this remote potential, Healthcare IT News reported in September 2024 that researchers from the Chinese University of Hong Kong and ETH Zurich successfully conducted a biopsy on a live porcine model over a distance of 5,700 miles, controlling a magnetic endoscope in Hong Kong from a console in Switzerland.

Simultaneously, the emergence of autonomous navigation and magnetic steering capabilities is revolutionizing the invasiveness and workflow of endoscopic examinations. Unlike traditional manually pushed instruments or mechanically actuated catheters, these next-generation platforms utilize external magnetic fields to precisely guide ingestible capsules or soft scopes through the digestive tract, significantly reducing patient discomfort and often eliminating the need for sedation. This shift toward magnetically driven, tether-free mobility minimizes tissue trauma and streamlines the procedural footprint, facilitating use in diverse clinical settings. Highlighting the commercial momentum of this technology, The Robot Report noted in June 2024 that Endiatx secured $7 million in funding to advance the clinical development of its PillBot system, a swallowable robotic capsule that physicians can actively steer inside the stomach.

Key Market Players

  • Asensus Surgical Inc
  • Intuitive Surgical Inc
  • Auris Health Inc
  • Johnson & Johnson Services, Inc.
  • Brainlab AG
  • Medtronic PLC
  • Boston Scientific Corp
  • Stryker Corp

Report Scope

In this report, the Global Robot-assisted Endoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Robot-assisted Endoscope Market, By End User

  • Hospitals
  • Outpatient Facilities
  • Others

Robot-assisted Endoscope Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Robot-assisted Endoscope Market.

Available Customizations:

Global Robot-assisted Endoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Robot-assisted Endoscope Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By End User (Hospitals, Outpatient Facilities, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Robot-assisted Endoscope Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By End User
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Robot-assisted Endoscope Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By End User
    • 6.3.2. Canada Robot-assisted Endoscope Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By End User
    • 6.3.3. Mexico Robot-assisted Endoscope Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By End User

7. Europe Robot-assisted Endoscope Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By End User
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Robot-assisted Endoscope Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By End User
    • 7.3.2. France Robot-assisted Endoscope Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By End User
    • 7.3.3. United Kingdom Robot-assisted Endoscope Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By End User
    • 7.3.4. Italy Robot-assisted Endoscope Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By End User
    • 7.3.5. Spain Robot-assisted Endoscope Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By End User

8. Asia Pacific Robot-assisted Endoscope Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By End User
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Robot-assisted Endoscope Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By End User
    • 8.3.2. India Robot-assisted Endoscope Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By End User
    • 8.3.3. Japan Robot-assisted Endoscope Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By End User
    • 8.3.4. South Korea Robot-assisted Endoscope Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By End User
    • 8.3.5. Australia Robot-assisted Endoscope Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By End User

9. Middle East & Africa Robot-assisted Endoscope Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By End User
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Robot-assisted Endoscope Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By End User
    • 9.3.2. UAE Robot-assisted Endoscope Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By End User
    • 9.3.3. South Africa Robot-assisted Endoscope Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By End User

10. South America Robot-assisted Endoscope Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By End User
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Robot-assisted Endoscope Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By End User
    • 10.3.2. Colombia Robot-assisted Endoscope Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By End User
    • 10.3.3. Argentina Robot-assisted Endoscope Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Robot-assisted Endoscope Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Asensus Surgical Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Intuitive Surgical Inc
  • 15.3. Auris Health Inc
  • 15.4. Johnson & Johnson Services, Inc.
  • 15.5. Brainlab AG
  • 15.6. Medtronic PLC
  • 15.7. Boston Scientific Corp
  • 15.8. Stryker Corp

16. Strategic Recommendations

17. About Us & Disclaimer